Business

Stellantis CEO says automaker is stronger together as stock plummets amid $26 billion charge
White House launches direct-to-consumer drug site TrumpRx. Here's what to know
White House launches direct-to-consumer drug site Trump Rx. Here's what to know
Bob's Discount Furniture closes flat in NYSE trading debut after pricing at $17 a share
Peloton shares plunge 26% on weak holiday quarter, sluggish demand for splashy new products
The White House is launching direct-to-consumer drug site Trump Rx. Here's what to know
White House to launch direct-to-consumer drug site Trump Rx. Here's what to know
Bob's Discount Furniture rises 2% in NYSE trading debut after pricing at $17 a share
Bob's Discount Furniture opens flat at $17 a share in muted NYSE trading debut
Estée Lauder expects $100 million tariff hit to full-year profitability; stock sinks more than 20%
Kalshi expands surveillance, enforcement efforts ahead of Super Bowl 60
Bob's Discount Furniture to start trading on NYSE as consumers seek value
Cheaper tequila and canned cocktails were the only bright spots for booze during a rough 2025
Peloton shares plunge more than 20% on weak holiday quarter, sluggish demand for splashy new products
Peloton posts weak holiday quarter after splashy product overhaul fails to land
E.l.f. Beauty posts earnings beat, raises full-year guidance
E.l.f. Beauty stock soars 15% on big earnings beat, raised guidance
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Yum Brands posts mixed quarter, Taco Bell shines
A surprising share of homeowners have high mortgage rates. Here's the breakdown
Streaming-only Super Bowl ads give small brands a shot at the big game
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar
Chipotle stock sinks as restaurant chain reports falling traffic, weak guidance
Chipotle stock sinks 11% as restaurant chain reports falling traffic, weak guidance
Chipotle earnings top estimates, but traffic to its restaurants fell again
Patriots owner Robert Kraft responds to Hall of Fame controversy
December CRE deal volume sinks further, but office is a surprising bright spot
AI will supercharge sports team valuations, says Arctos Partners’ Charles
Inside Alts: AI will supercharge sports team valuations, says Arctos Partners’ Charles
Who is Josh D'Amaro, Disney's next CEO?
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms
Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18
Property Play: December CRE deal volume sinks further, but office is a surprising bright spot
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
PepsiCo's drink sales are improving, and it's planning to cut snack prices
PepsiCo earnings beat estimates as drinks sales pick up around the world
New York AG issues warning around prediction markets ahead of Super Bowl
Here are the retailers with the most store openings and closures planned for 2026
GameStop's Ryan Cohen eyes 'very big' consumer megadeal that could increase company's value tenfold
Disney supercharged its parks. The booming division still has room to run
Disney signals its next CEO will take over a company with strong momentum
'Melania' earns a surprising $7 million, the highest opening for a nonmusic documentary in a decade
Disney beats Wall Street expectations propelled by theme parks and streaming
Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Hollywood has a box office problem: The old movie sequel trick is falling flat
Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launch
Ford to record $600 million pretax pension charge in fourth quarter
Hollywood has an IP problem: Box-office sales are banking on franchise hits that keep falling flat
Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections